Title: CBD is Out of the Block—Can Science Catch Up?
Date/Time: Tuesday, February 26, 2019 | 2 - 4 PM ET
The market for hemp-derived food, supplement and personal care products containing CBD has exploded—surpassing $190 million, by some estimations. And it is expected to skyrocket beyond $650 million in another five years. Product formulators add hemp extracts with CBD to pills, powders, liquids and gummies with claims of mood-enhancement, better sleep, and pain relief. However, FDA has recently reminded stakeholders that it remains technically unlawful to market CBD as an ingredient because CBD is an active ingredient in an FDA-approved drug and was the subject of substantial clinical investigations prior to being marketed in foods or supplements. At the same time, the agency has noted that there are pathways available for those who seek to lawfully introduce hemp extracts with CBD into interstate commerce. But, these pathways must be lit by science—and the publicly available research on the many variations of hemp-derived CBD products reveals that the science behind this compound is still nascent.
CRN and Natural Products INSIDER present this webinar to help companies better understand hemp-derived CBD products, how CBD works, and learn about the existing body of evidence supporting the safety and benefits of products that contain this ubiquitous ingredient.
During our webinar, experts will discuss:
CBD’s mechanism of action on the endocannabinoid system through the lens of pre-clinical evidence
The state of the science of human trials and case studies on CBD—including some currently underway
Identifying and filling research gaps
Translating existing scientific data into product claims that meet the fundamental requirements for substantiation
Join us to learn more about the science supporting CBD containing products and its role in regulatory compliance and market growth.
A Q&A period will follow speaker presentations.
Rend Al-Mondhiry, Senior Counsel, Amin Talati Upadhye, LLP
Susan J. Hewlings, Ph.D., R.D., Director of Scientific Affairs, Nutrasource
Hector Lopez, M.D., CSCS, FAAPMR, FISSN, Co-Founder, Supplement Safety Solutions, LLC;
CMO, Center for Applied Health Sciences, LLC
Duffy MacKay, N.D., Senior Vice President, Scientific & Regulatory Affairs, CRN